Budapest, Hungary

Gy Uml/o/ Szvoboda

This inventor holds 1 USPTO granted patent. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gy Uml/o/ Szvoboda. Retrieved from https://idiyas.com/inventor/gy-umlo-szvoboda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Gyula Szvoboda – Innovator in Antibiotic Research**

Introduction

Gyula Szvoboda, an accomplished inventor based in Budapest, Hungary, has made significant contributions to the field of antibiotic research. With a focus on microbiology, Szvoboda's work primarily involves the development of cultures capable of producing crucial therapeutic agents.

Latest Patents

Szvoboda holds a patent for a culture of Micromonospora rosea, which is known to be capable of producing the antibiotic sisomicin. This invention represents a vital advancement in antibiotic production, offering a potential treatment option for bacterial infections.

Career Highlights

Szvoboda is associated with Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt., a prominent pharmaceutical company in Hungary. His tenure at this organization highlights his dedication to advancing pharmaceutical sciences and developing new medicinal products for the market.

Collaborations

Throughout his career, Szvoboda has collaborated with notable colleagues, including Istvan Gado and Antonia Jekkel nee Bokany. These partnerships have fostered a fruitful environment for innovation and have contributed to the expansion of knowledge and expertise in antibiotic research.

Conclusion

In summary, Gyula Szvoboda exemplifies the spirit of innovation within the medical field. His work on the Micromonospora culture not only demonstrates the potential for new antibiotics but also emphasizes the importance of collaboration among scientists in driving advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…